‘Groundbreaking’ drug could slow progression of type 1 diabetes

Hannah Robinson, who is the first adult in the UK to try the drug Teplizumab in the hope it can delay diabetes (Royal Devon University Healthcare NHS Foundation Trust/PA) - (PA Media)

A ‘groundbreaking’ drug to slow down the development of type 1 diabetes is being tried by a handful of patients in the UK.

Teplizumab, which is already approved in the US, trains the immune system to stop attacking pancreatic cells, delaying the need for insulin by an average of three years.